Marex vs SOS
MRX and SOS side by side, both in security & commodity brokers, dealers, exchanges & services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MRX and SOS compare
Marex grew revenue faster over the last twelve months (26.9% versus −33.3% for SOS).
Marex keeps more of each dollar of sales as profit, with a net margin of 14.5% compared with −63.1% at SOS.
Marex scores higher on the StockData Score (9 against 5 for SOS), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MRX | SOS |
|---|---|---|
| Size and price | ||
| Share price | $70.72 | $0.206 |
| Change, 1 year | 103% | −86.4% |
| Change, 5 years | – | −100.0% |
| Beta (5Y) | 0.46 | 1.33 |
| Employees | 3,109 | 51 |
| StockData Score | ||
| Total score | 9 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 3 | 5 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 26.9% (better) | −33.3% |
| Revenue growth, 5Y average | – | 25.1% |
| Net income growth (TTM) | 43.6% | – |
| EPS growth (TTM) | 41.9% | – |
| Profitability | ||
| Gross margin | – | 1.5% |
| Operating margin | – | −63.9% |
| Net margin | 14.5% (better) | −63.1% |
| FCF margin | 32.3% (better) | −160% |
| Return on equity | 28.7% | – |
| Financial health | ||
| Debt / equity | 0.17 | – |
| Net debt / EBITDA | −2.22 | – |
| Current ratio | 1.09 | 9.72 (better) |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Payout ratio | 18.9% | – |
| Ownership | ||
| Held by institutions | 77.6% | – |
| Held by insiders | 8.4% | 18.4% |
| Insider net buying, 12 months | −$19.8M | −$63.3K (better) |
| Short interest, % of float | 3.3% | – |
Go deeper
- MRX stock overview
- MRX income statement
- MRX valuation and score
- SOS stock overview
- SOS income statement
- SOS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.